BiotechTube
Home/35Pharma/Maureen O’Connor
MO

Maureen O’Connor

Chief Scientific Officer

35Pharma

Therapeutic Areas

Pulmonary HypertensionHeart FailureObesity

35Pharma Pipeline

DrugIndicationPhase
HS235Pulmonary Arterial Hypertension, PH‑HFpEFPhase 1/2
HS370Heart Failure, ObesityPreclinical

Leadership Team at 35Pharma

IT
Ilia Tikhomirov
Chief Executive Officer
GG
George Georges
Chief Medical Officer
View full 35Pharma profile